ALFUZOSIN HYDROCHLORIDE (DirectRX)
Welcome to the PulseAid listing for the ALFUZOSIN HYDROCHLORIDE drug offered from DirectRX. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | DirectRX |
NON-PROPRIETARY NAME: | ALFUZOSIN HYDROCHLORIDE |
SUBSTANCE NAME: | ALFUZOSIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-12-21 |
END MARKETING DATE: | 0000-00-00 |
ALFUZOSIN HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | ALFUZOSIN HYDROCHLORIDE from DirectRX |
LABELER NAME: | DirectRX |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2015-12-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61919-349_27f6bec9-90aa-4c4c-e054-00144ff8d46c |
PRODUCT NDC: | 61919-349 |
APPLICATION NUMBER: | ANDA079057 |
Other ALFUZOSIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: